Psychiatry and Neurology, Epilepsy · Spokane, WA
NPI
1982697090
Since 2005
Specialty
Psychiatry and Neurology, Epilepsy
Code 2084E0001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
105 W 8th Ave, Suite 318c
Spokane, WA, 99204
Phone (509) 474-6650
Groups this clinician bills Medicare through
Medicare paid, 2024
$74K
855 services
Medicare patients, 2024
504
Average age 65
Drug cost, 2024
$1.4M
5,353 prescriptions
Company payments, 2025
$150
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy W Powell was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 142 times for 140 patients. In total Timothy W Powell billed 855 services in 23 codes, and Medicare paid $74K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 142 | 140 | $11.26 | $1,599 |
| 95720 Neurologic | Facility | 139 | 75 | $157.68 | $22K |
| 99214 Office E&M - Established | Office | 115 | 109 | $68.95 | $7,930 |
| 99213 Office E&M - Established | Office | 107 | 106 | $50.23 | $5,375 |
| 95717 Neurologic | Facility | 56 | 55 | $80.46 | $4,506 |
| 95816 Neurologic | Facility | 49 | 49 | $40.34 | $1,977 |
| 95819 Neurologic | Office | 31 | 30 | $345.40 | $11K |
| 95813 Neurologic | Facility | 29 | 29 | $61.67 | $1,788 |
| 99205 Office E&M - New | Office | 29 | 29 | $148.41 | $4,304 |
| 95819 Neurologic | Facility | 26 | 25 | $37.22 | $968 |
| 95718 Neurologic | Facility | 25 | 24 | $103.95 | $2,599 |
| 95970 Electrical Nerve Conductivity | Office | 20 | 19 | $10.29 | $206 |
| 99215 Office E&M - Established | Office | 18 | 18 | $118.17 | $2,127 |
| 95816 Neurologic | Office | 18 | 18 | $308.46 | $5,552 |
By year: 2022 $65K for 748 services; 2023 $70K for 767 services; 2024 $74K for 855 services.
Medicare prescription drug claims, 2024
In 2024, the drug Timothy W Powell prescribed most often to Medicare patients was Lamotrigine, with 1,141 prescriptions and refills. In total Timothy W Powell wrote 5,353 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 1,141 | 1,900 | 240 | $30K |
| Levetiracetam Generic | 748 | 1,254 | 177 | $29K |
| Topiramate Generic | 405 | 571 | 70 | $5,988 |
| Zonisamide Generic | 288 | 439 | 67 | $16K |
| Divalproex Sodium Generic | 180 | 221 | 33 | $13K |
| Lacosamide Generic | 172 | 246 | 48 | $23K |
| Divalproex Sodium Er Divalproex Sodium | 140 | 164 | 24 | $18K |
| Gabapentin Generic | 138 | 220 | 35 | $4,035 |
| Lamotrigine Er Lamotrigine | 136 | 213 | 27 | $40K |
| Carbamazepine Er Carbamazepine | 115 | 173 | 22 | $24K |
| Clobazam Generic | 102 | 131 | 24 | $6,567 |
| Lamictal Lamotrigine | 95 | 103 | 11 | $110K |
| Oxcarbazepine Generic | 80 | 102 | 18 | $5,455 |
| Carbamazepine Generic | 75 | 109 | 14 | $7,207 |
| Topamax Topiramate | 67 | 71 | Under 11 | $79K |
Brand drugs: 655 claims; generic drugs: 4,661 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy W Powell $150 ($150 in general payments such as food, travel and fees) from 1 company. The largest payer was LivaNova USA, Inc. with $150.
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. LIVN | 9 | $150 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.